KYMERA THERAPEUTICS, INC. (KYMR) /
The debt of KYMERA THERAPEUTICS, INC. over the past 7 years
Chart KYMERA THERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2019–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, KYMERA THERAPEUTICS, INC. had liquid cash of $848.28M and total debt of $0: net cash of $848.28M. It had more liquid cash than debt at all 7 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $848.28M* | $0 | $848.28M |
| 2024ended Dec 31, 2024 | $488.74M* | $0 | $488.74M |
| 2023ended Dec 31, 2023 | $374.88M* | $0 | $374.88M |
| 2022ended Dec 31, 2022 | $407.17M* | $0 | $407.17M |
| 2021ended Dec 31, 2021 | $442.42M* | $0 | $442.42M |
| 2020ended Dec 31, 2020 | $296.2M* | $0 | $296.2M |
| 2019ended Dec 31, 2019 | $91.96M* | $0 | $91.96M |
Fiscal years as KYMERA THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on KYMERA THERAPEUTICS, INC.
- The revenue of KYMERA THERAPEUTICS, INC.
- The profitability of KYMERA THERAPEUTICS, INC.
- The cash flow of KYMERA THERAPEUTICS, INC.
- All of KYMERA THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- DDSDILLARD’S, INC.
- HIIHUNTINGTON INGALLS INDUSTRIES, INC.
- ARWARROW ELECTRONICS, INC.
- FNFFIDELITY NATIONAL FINANCIAL, INC.
- BMRNBIOMARIN PHARMACEUTICAL INC
Not investment advice. This page shows what KYMERA THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.